Kwality Pharmaceuticals Ltd (539997) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539997 | NSE: | Pharmaceuticals & Drugs | Small Cap

Kwality Pharma Share Price

895.70 7.70 0.87%
as on 05-Dec'25 16:59

Kwality Pharmaceuticals Ltd (539997) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539997 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Kwality Pharma

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Kwality Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
18.77
Market Cap:
921.4 Cr.
52-wk low:
596.1
52-wk high:
1,235

Is Kwality Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Kwality Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kwality Pharmaceuticals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 14%19.5%19.4%21.5%18.5%26.5%97.2%12.3%13.6%18.3%-
Value Creation
Index
-00.40.40.50.30.95.9-0.10.00.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 75.995.3137165139262456251307370423
Sales YoY Gr.-25.6%43.6%20.7%-16%88.6%74.4%-45%22.4%20.5%-
Adj EPS 2.13.74.57.3814.6114.62927.938.447.3
YoY Gr.-73.8%19.9%63%9.4%83.9%683.7%-74.7%-3.8%37.4%-
BVPS (₹) 21.624.629.236.544.659.5175.2193.9217255.4280.6
Adj Net
Profit
2.23.94.67.58.315.211930.12939.849
Cash Flow from Ops. -2.64-0.1135.626.459.242.243.452.8-
Debt/CF from Ops. -54.7-275.32.26.21.60.92.12.32.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 19.3%21.7%-6.7%20.5%
Adj EPS 37.8%37%-30.6%37.4%
BVPS31.6%41.8%13.4%17.7%
Share Price - 74.2% 39.5% 2.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
10.215.816.121.619.227.79715.713.516.217.7
Op. Profit
Mgn %
7.69.68.49.210.211.237.724.321.721.722
Net Profit
Mgn %
2.84.13.44.665.826.1129.410.811.6
Debt to
Equity
0.60.70.90.70.80.70.30.50.40.40
Working Cap
Days
139157155154203126129319276265120
Cash Conv.
Cycle
6978696378363314115115153

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Kwality Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 47.3 47.3
TTM Sales (₹ Cr.) 423 423
BVPS (₹.) 280.6 278.8
Reserves (₹ Cr.) 281 279
P/BV 3.17 3.18
PE 18.77 18.78
From the Market
52 Week Low / High (₹) 596.05 / 1235.00
All Time Low / High (₹) 20.43 / 1235.00
Market Cap (₹ Cr.) 921
Equity (₹ Cr.) 10.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Kwality Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Kwality Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Kwality Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales7695137165139262456251307370
Operating Expenses 7087125150125232284190241290
Manufacturing Costs458781379639395
Material Costs5870102119871661426990116
Employee Cost 2458111419283041
Other Costs 681116193944302838
Operating Profit 5911151429172616780
Operating Profit Margin (%) 7.1%9.0%8.4%9.2%10.2%11.2%37.6%24.3%21.7%21.7%
Other Income 1211424322
Interest 122233371010
Depreciation 22334611152018
Exceptional Items 0000000-17-70
Profit Before Tax 368111122162263154
Tax 123336426714
Profit After Tax 2358815120192440
PAT Margin (%) 2.5%3.6%3.4%4.6%6.1%5.9%26.3%7.8%7.8%10.8%
Adjusted EPS (₹)1.93.34.57.38.114.9115.718.823.138.4
Dividend Payout Ratio (%)0%9%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 232631394763183202226266
Share Capital 551010101010101010
Reserves 182121283752172192216255
Minority Interest0000000000
Debt12182526313543788698
Long Term Debt3347101820272015
Short Term Debt10152119211623516683
Trade Payables10132217232635354456
Others Liabilities 8151926334582414229
Total Liabilities 527298107134169343357398449

Fixed Assets

Gross Block212731406181127169205230
Accumulated Depreciation10121518202536496785
Net Fixed Assets 11141522425691120138144
CWIP 014603121400
Investments 5798894444
Inventories9141511221753867883
Trade Receivables2023373930387173116156
Cash Equivalents 121015116514
Others Assets 71117203141101535647
Total Assets 527298107134169343357398449

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -34-01362659424353
PBT 368111122162263154
Adjustment 34556914213728
Changes in Working Capital -7-4-91-92-752-23-14
Tax Paid -1-2-3-3-3-6-41-6-1-16
Cash Flow From Investing Activity -2-7-6-12-17-23-63-48-26-28
Capex -2-7-6-12-18-23-55-46-26-25
Net Investments -0-1-0-11-0-0000
Others 001100-8-3-1-4
Cash Flow From Financing Activity 555-212161-17-14
Net Proceeds from Shares 2100000000
Net Proceeds from Borrowing 211331097-7-5
Interest Paid -1-2-2-2-2-3-3-6-10-10
Dividend Paid 0-000000000
Others 356-312-70000
Net Cash Flow 01-1-1142-5-010

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.314.5816.7622.1720.0528.5598.6110.1711.2516.28
ROCE (%)13.9819.5119.3721.4718.5326.5197.1912.2813.6218.3
Asset Turnover Ratio1.681.531.611.611.151.721.780.720.810.87
PAT to CFO Conversion(x)-1.51.33-01.630.751.730.492.211.791.33
Working Capital Days
Receivable Days69818084914843105112134
Inventory Days364338294428281029880
Payable Days43596260845478183162157

Kwality Pharmaceuticals Ltd Stock News

Kwality Pharmaceuticals Ltd FAQs

The current trading price of Kwality Pharma on 05-Dec-2025 16:59 is ₹895.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Kwality Pharma stood at ₹921.4.
The latest P/E ratio of Kwality Pharma as of 04-Dec-2025 is 18.77.
The latest P/B ratio of Kwality Pharma as of 04-Dec-2025 is 3.17.
The 52-week high of Kwality Pharma is ₹1,235 and the 52-week low is ₹596.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kwality Pharma is ₹422.9 ( Cr.) .

About Kwality Pharmaceuticals Ltd

The company ‘Kwality Pharmaceuticals Limited’ was incorporated on May 04, 1983 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, H.P. and Chandigarh. It is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. It carries out its production through state-of-the-art manufacturing units situated at 6th Mile Stone, Village Nag Kalan, Majitha Road, Amritsar - 143006, Punjab, which is also its registered/administrative office and another manufacturing facility situated at 1-A Industrial Area, Raja ka bagh, Jassur, Himachal Pradesh. Both of its manufacturing facilities are well equipped and multiple products are manufactured at these facilities. Since incorporation, the company is ever progressing in Domestic and International market based on its commitment towards high quality and timely supplies. It provides specified and quality products for its customers while maintaining honesty, integrity and loyalty to its employees and customers.

The company has the most modern & sophisticated plant, equipments, technique and manpower. The company is ISO-9001:2000 and ISO 14001:2004 certified, and it is working with new SCHEDULE M and W.H.O. norms and certified with GMP and WHO certificate. The company’s production is based on standards laid down in pharmacopeia and technical reports series (TRS) guidelines of WHO (world health organization). 

Milestones

  • 1983: Incorporation of the company on May 04, 1983.
  • 2007: Received ISO Certification.
  • 2008: Commencement of new manufacturing unit at Jassur in Himachal Pradesh.
  • 2009: Received status of Star Export House Certificate.
  • 2012: Turnover increased by 75%.
  • 2013: Incorporation of Subsidiary Company in Africa.
  • 2014: Received WHO certification.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×